Medtronic is launching its CoreValve Evolut PRO transcatheter aortic valve in Europe after receiving CE mark approval from regulators. The device, designed with an external porcine pericardial tissue wrap to facilitate contact between the device and the natural valve opening, is indicated for treatment of severe aortic stenosis in patients who would be put at intermediate, high or extreme risk with open-heart surgery.
Medtronic debuts CoreValve Evolut PRO valve in Europe
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.